Clinical trial
DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval…
NCT03494920 · Neuroscience Trials Australia, Other · Completed
Key facts
| NCT number | NCT03494920 |
|---|---|
| Title | DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval |
| Official title | DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval Within 4.5 Hours of Stroke Onset |
| Lead sponsor | Neuroscience Trials Australia, Other |
| Collaborators | The Florey Institute of Neuroscience and Mental Health |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ischemic Stroke |
| Intervention type | Other |
| Interventions | Direct endovascular clot retrieval, Bridging thrombolysis followed by ECR |
| Enrollment | 295 |
| Start date | Apr 27, 2018 |
| Primary completion | Sep 8, 2021 |
| Completion | Sep 8, 2021 |
| First posted | Apr 11, 2018 |
| Last update posted | Jun 16, 2022 |
| Countries | Australia, China, Singapore, Vietnam |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: